Published in

American Society for Clinical Investigation, Journal of Clinical Investigation

DOI: 10.1172/jci124920

American Society for Clinical Investigation, Journal of Clinical Investigation, 2(128), p. 789-804

DOI: 10.1172/jci94516

Links

Tools

Export citation

Search in Google Scholar

JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition

Journal article published in 2018 by Anna Sophia McKenney, Mya Steadman, Katharine Yen, Matthew G. Vander Heiden, Julie Teruya-Feldstein, Kwok-Kin Wong, Craig B. Thompson, McKenney As, Allison N. Lau ORCID, Amritha Varshini Hanasoge Somasundara, Lau An, Andrew M. Intlekofer ORCID, Barbara Spitzer, Somasundara Avh, Jihae Ahn and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO